OEM Customized Esmolol HCl - Lasofoxifene Tartrate CAS 190791-29-8 Chiral Purity ≥99.0% Purity ≥98.0% (HPLC) API High Purity – Ruifu

Short Description:

Product Detail

Product Tags

Feedback (2)

The company upholds the philosophy of "Be No.1 in quality, be rooted on credit and trustworthiness for growth", will continue to serve old and new customers from home and overseas whole-heatedly for (R)-(-)-α-Methoxyphenylacetic Acid CAS 3966-32-3, CAS 438056-69-0, Molecular Formula C18H14BrNO3, With outstanding company and top quality, and an enterprise of overseas trade featuring validity and competitiveness, which will be trustworthy and welcomed by its clientele and makes joy to its employees.

OEM Customized Esmolol HCl - Lasofoxifene Tartrate CAS 190791-29-8 Chiral Purity ≥99.0% Purity ≥98.0% (HPLC) API High Purity – Ruifu Detail:

Manufacturer Supply with High Purity and Stable Quality
Chemical Name: Lasofoxifene Tartrate
CAS: 190791-29-8
Appearance: White to Off-White Powder
Chiral Purity: ≥99.0% Purity: ≥98.0% (HPLC)
Lasofoxifene Tartrate (CAS: 190791-29-8) in the treatment of Postmenopausal Osteoporosis

Chemical Name	Lasofoxifene Tartrate
Synonyms	(5R,6S)-5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-2-naphthalenol Tartrate Oporia
CAS Number	190791-29-8
CAT Number	RF-API20
Stock Status	In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula	C28H31NO2.ClH
Molecular Weight	450.019
Brand	Ruifu Chemical

Item	Specifications
Appearance	White to Off-White Powder
Moisture (K.F)	≤0.50%
Heavy Metals	≤20ppm
Chiral Purity	≥99.0%
Purity / Analysis Method	≥98.0% (HPLC)
Loss on Drying	≤0.50%
Residue on Ignition	≤0.50%
Test Standard	Chinese Pharmacopoeia (CP); Enterprise Standard
Usage	Active Pharmaceutical Ingredient (API); Postmenopausal Osteoporosis

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Lasofoxifene Tartrate (CAS: 190791-29-8) with high quality.
Lasofoxifene Tartrate is a third-generation, non-steroidal selective estrogen receptor modulator (SERM). It selectively binds to human ERalpha with an IC50 value of 1.5 nM and inhibits bone loss in ovariectomized rats. In clinical studies of postmenopausal osteoporosis, 0.5 mg/day lasofoxifene was associated with reduced risks of nonvertebral and vertebral fractures, ER-positive breast cancer, coronary heart disease, and stroke but an increased risk of venous thromboembolic events. Lasofoxifene has also been shown to act as an inverse agonist at the CB2 cannabinoid receptor, indicating its potential to be repurposed as a therapeutic for indications wherein CB2 is a target.

Product detail pictures:

Related Product Guide:

continue to improve, to ensure product quality in line with market and customer standard requirements. Our company has a quality assurance system have been established for OEM Customized Esmolol HCl - Lasofoxifene Tartrate CAS 190791-29-8 Chiral Purity ≥99.0% Purity ≥98.0% (HPLC) API High Purity – Ruifu , The product will supply to all over the world, such as: British, Johor, Orlando, With the enterprising spirit of" high efficiency, convenience, practicality and innovation", and in line with such serving guidance of "good quality but better price, " and "global credit", we've been striving to cooperate with the automobile parts companies all over the world to make a win-win partnership.